Publikasjoner

Her finner du oversikt over forskergruppens utvalgte publikasjoner gjennom flere år.

Utvalgte publikasjoner

  • Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D (2011). An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses. J Virol, 85 (13), 6557-66. PubMed 21490090
  • van der Helm JJ, Prins M, del Amo J, Bucher HC, Chêne G, Dorrucci M, Gill J, Hamouda O, Sannes M, Porter K, Geskus RB, CASCADE Collaboration (2011). The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS, 25 (8), 1083-91. PubMed 21537114
  • Bratholm C, Johannessen A, Naman E, Gundersen SG, Kivuyo SL, Holberg-Petersen M, Ormaasen V, Bruun JN (2010). Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital. J Antimicrob Chemother, 65 (9), 1996-2000. PubMed 20576637
  • Kran AM, Jonassen TO, Sommerfelt MA, Løvgården G, Sørensen B, Kvale D (2010). Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides. AIDS, 24 (17), 2609-18. PubMed 20935558
  • Skeie L, Bugge H, Negaard A, Bergersen BM (2010). Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study. HIV Med, 11 (3), 170-7. PubMed 19780861
  • Maagaard A, Kvale D (2009). Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms? J Antimicrob Chemother, 64 (5), 901-9. PubMed 19740910
  • Baba K, Hoosen AA, Langeland N, Dyrhol-Riise AM (2008). Adenosine deaminase activity is a sensitive marker for the diagnosis of tuberculous pleuritis in patients with very low CD4 counts. PLoS One, 3 (7), e2788. PubMed 18665218
  • Maagaard A, Holberg-Petersen M, Løvgården G, Holm M, Pettersen FO, Kvale D (2008). Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment. J Infect Dis, 198 (10), 1474-81. PubMed 18851688
  • Kvale D, Ormaasen V, Kran AM, Johansson CC, Aukrust P, Aandahl EM, Frøland SS, Taskén K (2006). Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment. AIDS, 20 (6), 813-20. PubMed 16549964
  • Kvale D, Kran AM, Sommerfelt MA, Nyhus J, Baksaas I, Bruun JN, Sørensen B (2005). Divergent in vitro and in vivo correlates of HIV-specific T-cell responses during onset of HIV viraemia. AIDS, 19 (6), 563-7. PubMed 15802974
Publisert 2. mai 2013 12:58 - Sist endret 23. feb. 2017 09:14